IRAs published in 50(6)
No comments were received when the following proposals were published:
- Norflurane
- Xylazine
- Xylazine Injection
Commentary for IRAs published on April 25, 2025
- Polyethylene Glycol
- Xylazine Hydrochloride
IRAs published in 50(5)
No comments were received when the following proposals were published:
- Rufinamide
IRAs published in 50(4)
No comments were received when the following proposals were published
- Dimethyl Fumarate Delayed-Release Capsules
- Protriptyline Hydrochloride
IRAs published in 50(3)
No comment were received when the following proposal was published
- Methylprednisolone Acetate Injectable Suspension
IRAs published in 50(2)
No comments were received when the following proposals were published
- Gadopentetate Dimeglumine Injection
Commentary for IRAs published on September 27, 2024
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
IRAs published in 50(1)
- Commentary (posted 28-Jun-2024)
- Clonidine Transdermal System
- Norgestimate